loadpatents
name:-0.13219714164734
name:-0.024740934371948
name:-0.0021440982818604
Norris; Derek J. Patent Filings

Norris; Derek J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Norris; Derek J..The latest application filed is for "nlrp3 modulators".

Company Profile
2.27.32
  • Norris; Derek J. - Pennington NJ
  • Norris; Derek J. - Hopewell NJ
  • Norris; Derek J. - Trenton NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Nlrp3 Modulators
App 20220089571 - O'Malley; Daniel ;   et al.
2022-03-24
Nlrp3 Modulators
App 20220089572 - Gavai; Ashvinikumar V. ;   et al.
2022-03-24
Cyclic Protein Tyrosine Kinase Inhibitors
App 20190210986 - Das; Jagabandhu ;   et al.
2019-07-11
Tricyclic compounds as anticancer agents
Grant 10,112,941 - Norris , et al. October 30, 2
2018-10-30
Cyclic Protein Tyrosine Kinase Inhibitors
App 20180016247 - Das; Jagabandhu ;   et al.
2018-01-18
Novel Tricyclic Compounds As Anticancer Agents
App 20170327498 - Norris; Derek J. ;   et al.
2017-11-16
Tricyclic compounds as anticancer agents
Grant 9,751,879 - Norris , et al. September 5, 2
2017-09-05
Tricyclic compounds as anticancer agents
Grant 9,725,449 - Norris , et al. August 8, 2
2017-08-08
Tricyclic Compounds As Anticancer Agents
App 20160333013 - Norris; Derek J. ;   et al.
2016-11-17
Carbazole compounds useful as bromodomain inhibitors
Grant 9,492,460 - Poss , et al. November 15, 2
2016-11-15
Novel Tricyclic Compounds As Anticancer Agents
App 20160326173 - Norris; Derek J. ;   et al.
2016-11-10
Tricyclic Compounds As Anticancer Agents
App 20160318928 - Norris; Derek J. ;   et al.
2016-11-03
Tricyclic compounds as anticancer agents
Grant 9,458,156 - Norris , et al. October 4, 2
2016-10-04
Novel Tricyclic Compounds As Anticancer Agents
App 20160176864 - Norris; Derek J. ;   et al.
2016-06-23
Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds
Grant 9,242,941 - Gavai , et al. January 26, 2
2016-01-26
Alkyl, Fluoroalkyl-1,4-benzodiazepinone Compounds
App 20150239851 - Gavai; Ashvinikumar V. ;   et al.
2015-08-27
Carbazole Compounds Useful As Bromodomain Inhibitors
App 20140256700 - Poss; Michael A. ;   et al.
2014-09-11
Cyclic protein tyrosine kinase inhibitors
Grant 8,716,323 - Das , et al. May 6, 2
2014-05-06
Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
Grant 8,067,582 - Norris , et al. November 29, 2
2011-11-29
Crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazi- n-5-yl]methyl]piperidin-3-ol
Grant 8,063,208 - Wei , et al. November 22, 2
2011-11-22
Pyrrolotriazine Compounds As Kinase Inhibitors
App 20110039838 - Fink; Brian E. ;   et al.
2011-02-17
Fused Heterocyclic Compounds Useful As Modulators Of Nuclear Hormone Receptor Function
App 20100331324 - Norris; Derek J. ;   et al.
2010-12-30
Pyrrolotriazine compounds as kinase inhibitors
Grant 7,846,931 - Fink , et al. December 7, 2
2010-12-07
Pyrrolotriazine Compounds As Kinase Inhibitors
App 20090048244 - Fink; Brian E. ;   et al.
2009-02-19
Fused tricyclic compounds as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3
Grant 7,417,040 - Fink , et al. August 26, 2
2008-08-26
Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
Grant 7,405,213 - Chen , et al. July 29, 2
2008-07-29
Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
Grant 7,402,582 - Gavai , et al. July 22, 2
2008-07-22
Fused heterotricyclic compounds as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3
Grant 7,378,426 - Gavai , et al. May 27, 2
2008-05-27
Pyrrolotriazine compounds as kinase inhibitors
Grant 7,297,695 - Fink , et al. November 20, 2
2007-11-20
CRYSTALLINE FORMS OF (3R,4R)-4-AMINO-1-[[4-[(3-METHOXYPHENYL)AMINO]PYRROLO[2,1-f][1,2,4]TRIAZI- N-5-YL]METHYL]PIPERIDIN-3-OL
App 20070191375 - Wei; Chenkou ;   et al.
2007-08-16
Cyclic protein tyrosine kinase inhibitors
Grant 7,189,854 - Das , et al. March 13, 2
2007-03-13
Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
App 20070004732 - Gavai; Ashvinikumar V. ;   et al.
2007-01-04
Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
App 20070004733 - Chen; Ping ;   et al.
2007-01-04
Cyclic protein tyrosine kinase inhibitors
Grant 7,153,856 - Barrish , et al. December 26, 2
2006-12-26
Pyrrolotriazine compounds as kinase inhibitors
Grant 7,141,571 - Fink , et al. November 28, 2
2006-11-28
Pyrrolotriazine Compounds As Kinase Inhibitors
App 20060264438 - Fink; Brian E. ;   et al.
2006-11-23
Cyclic protein tyrosine kinase inhibitors
Grant 7,125,875 - Das , et al. October 24, 2
2006-10-24
Process for preparing pyrrolotriazine
Grant 7,102,001 - Swaminathan , et al. September 5, 2
2006-09-05
Cyclic protein tyrosine kinase inhibitors
Grant 7,091,223 - Das , et al. August 15, 2
2006-08-15
Synthetic process
App 20060155125 - Chen; Ping ;   et al.
2006-07-13
Di-substituted pyrrolotriazine compounds
Grant 7,064,203 - Gavai , et al. June 20, 2
2006-06-20
Cyclic protein tyrosine kinase inhibitors
App 20060079563 - Das; Jagabandhu ;   et al.
2006-04-13
Cyclic protein tyrosine kinase inhibitors
App 20050288303 - Barrish, Joel C. ;   et al.
2005-12-29
Cyclic protein tyrosine kinase inhibitors
Grant 6,979,694 - Das , et al. December 27, 2
2005-12-27
Cyclic protein tyrosine kinase inhibitors
App 20050261305 - Das, Jagabandhu ;   et al.
2005-11-24
Fused tricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogenase 3
App 20050250753 - Fink, Brian E. ;   et al.
2005-11-10
Synthetic process
App 20050209454 - Swaminathan, Shankar ;   et al.
2005-09-22
Di-substituted pyrrolotrizine compounds
App 20050197339 - Gavai, Ashvinikumar V. ;   et al.
2005-09-08
Fused heterotricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogenase 3
App 20050192310 - Gavai, Ashvinikumar V. ;   et al.
2005-09-01
Pyrrolotriazine compounds as kinase inhibitors
App 20050182058 - Fink, Brian E. ;   et al.
2005-08-18
Cyclic protein tyrosine kinase inhibitors
App 20040077875 - Das, Jagabandhu ;   et al.
2004-04-22
Cyclic protein tyrosine kinase inhibitors
App 20040073026 - Das, Jagabandhu ;   et al.
2004-04-15
Cyclic protein tyrosine kinase inhibitors
App 20040054186 - Das, Jagabandhu ;   et al.
2004-03-18
Cyclic protein tyrosine kinase inhibitors
App 20040024208 - Das, Jagabandhu ;   et al.
2004-02-05
Cyclic protein tyrosine kinase inhibitors
Grant 6,596,746 - Das , et al. July 22, 2
2003-07-22
Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
App 20020119972 - Leftheris, Katerina ;   et al.
2002-08-29
Imidazoquinoxaline protein tyrosine kinase inhibitors
Grant 6,235,740 - Barrish , et al. May 22, 2
2001-05-22
Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
Grant 5,990,109 - Chen , et al. November 23, 1
1999-11-23
Company Registrations
SEC0001452499NORRIS DEREK J

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed